Evaluation of the Therapeutic Potential of Warburgia ugandensis, Prunus africana, and Piliostigma thonningii against Leishmania donovani in vitro and in Balb/c Mice

Authors

  • Maria Divinah Mogaka Department of Zoological Sciences of the School of Pure and Applied Sciences, Kenyatta University, Kenya
  • Joshua M. Mutiso Department of Zoological Sciences of the School of Pure and Applied Sciences, Kenyatta University, Kenya
  • John C. Macharia Department of Tropical and Infectious Diseases, Institute of Primate Research, Kenya
  • Rebecca M. Ayako Department of Zoological Sciences of the School of Pure and Applied Sciences, Kenyatta University, Kenya
  • Bernard Osero Centre for Biotechnology Research and Development, Kenya Medical Research Institute, Kenya
  • Michael M. Gicheru Department of Zoological Sciences of the School of Pure and Applied Sciences, Kenyatta University, Kenya

DOI:

https://doi.org/10.30564/jzr.v4i4.4926

Abstract

Leishmaniasis is a zoonotic disease caused by protozoan parasites of the genus Leishmania. Conventional chemotherapy remains to be the most preferred measure against leishmaniasis despite being associated with high toxicity and relapse rates. They are also expensive and require hospitalization. Plant-based compounds provide a better treatment alternative because they are effective, cheap, and less associated with toxicity and resistance. This study examined the therapeutic potential of Warburgia ugandensis, Prunus africana, and Piliostigma thonningii against Leishmania donovani infection in BALB/c mice. Anti-promastigote and toxicity studies were evaluated by incubating the test compound with promastigotes and Vero cells, respectively. Serum was obtained from the mice for total immunoglobulin gamma (IgG) quantification. For in vivo studies, the mice were infected with virulent Leishmania donovani then treated with methanolic extracts of Warburgia ugandensis, Prunus africana, and Piliostigma thonningii and control drug, pentostam (sodium stibogluconate). Treatment with the plant extracts and standard drug resulted to significant reduction in parasite burden. Outcomes in the mice treated with plant extracts were comparable to those treated with pentostam (P≥0.05). In the promastigote assay, all the test compounds killed more than half of the promastigotes at the highest concentration (500 µg/mL). Warburgia ugandensis, P. thonningii, and P. africana reduced the number of promastigotes from 2.0 × 106 to 7.7 × 103 , 72.0 × 103 , and 5.0 × 103 , respectively. Pentostam had the lowest IC50 (210 µg/mL), followed by Warburgia ugandensis (IC50 of 270 µg/mL). Piliostigma thonningii and P. africana were less toxic with IC50 of 720 µg/mL and 500 µg/mL, respectively. There was low production of IgG antibodies following treatment with the plant extracts and high levels in the untreated control.

Keywords:

Promastigotes; Amastigotes; Toxicity; Parasite burden; IgG antibodies

References

[1] World health organization (WHO), 2022. Leishmaniasis. Available at: https://www.who.int/news-room/ fact-sheets/detail/leishmaniasis.

[2] Ouma, F.F., Mulambalah, C.S., 2021. Persistence and changing distribution of leishmaniases in Kenya require a paradigm shift. Journal of Parasitology Research. 1-6. DOI: https://doi.org/10.1155/2021/9989581

[3] Ali Al-Hajj, M.M., Al-Shamahy, H.A., Alkhatib, B.Y., et al., 2018. In vitro anti-leishmanial activity against cutaneous leishmania parasites and preliminary phytochemical analysis of four yemeni medicinal plants. Universal Journal of Pharmaceutical Research. DOI: https://doi.org/10.22270/ujpr.v3i4.183

[4] Mann, S., Frasca, K., Scherrer, S., et al., 2021. A review of leishmaniasis: Current knowledge and future directions. Current Tropical Medicine Reports. 8(2), 121-132. DOI: https://doi.org/10.1007/s40475-021-00232-7

[5] Moraes Neto, R.N., Setúbal, R.F., Higino, T.M., et al., 2019. Asteraceae plants as sources of compounds against leishmaniasis and Chagas disease. Frontiers in Pharmacology. 10. DOI: https://doi.org/10.3389/fphar.2019.00477

[6] Selvapandiyan, A., Croft, S.L., Rijal, S., et al., 2019. Innovations for the elimination and control of visceral leishmaniasis. PLOS Neglected Tropical Diseases. 13(9), e0007616. DOI: https://doi.org/10.1371/journal.pntd.0007616

[7] Badirzadeh, A., Heidari-Kharaji, M., Fallah-Omrani, V., et al., 2020. Antileishmanial activity of urtica dioica extract against zoonotic cutaneous leishmaniasis. PLOS Neglected Tropical Diseases. 14(1), e0007843. DOI: https://doi.org/10.1371/journal.pntd.0007843

[8] Ngure, P., Ng’ang’a, Z., Kimutai, A., et al., 2014. Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (canellaceae) by Balb/C mice infected with leishmania major. Pan African Medical Journal. 17. DOI: https://doi.org/10.11604/pamj.supp.2014.17.1.3638

[9] Githinji, E., Irungu, L., Tonui, W., et al., 2010. In vitro effects of Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens on Leishmania major promastigotes. African Journal of Traditional, Complementary and Alternative Medicines. 7(3). DOI: https://doi.org/10.4314/ajtcam.v7i3.54791

[10] Afolayan, M., Srivedavyasasri, R., Asekun, O.T., et al., 2018. Phytochemical study of Piliostigma thonningii, a medicinal plant grown in Nigeria. Medicinal Chemistry Research. 27(10), 2325-2330. DOI: https://doi.org/10.1007/s00044-018-2238-1

[11] Karani, L., Tolo, F., Karanja, S., et al., 2013. Safety of Prunus africana and Warburgia ugandensis in asthma treatment. South African Journal of Botany. 88, 183-190. DOI: https://doi.org/10.1016/j.sajb.2013.07.007

[12] Mutiso, J.M., Macharia, J.C., Barasa, M., et al., 2011. In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against leishmania donovani in BALB/C mice. Revista do Instituto de Medicina Tropical de São Paulo. 53(3), 129-132. DOI: https://doi.org/10.1590/s0036-46652011000300003

[13] Jumba, B.N., Anjili, C.O., Makwali, J., et al., 2015. Evaluation of leishmanicidal activity and cytotoxicity of ricinus communis and Azadirachta indica extracts from western Kenya: In vitro and in vivo assays. BMC Research Notes. 8(1). DOI: https://doi.org/10.1186/s13104-015-1605-y

[14] Marango, S.N., Khayeka-Wandabwa, C., Makwali, J.A., et al., 2017. Experimental therapeutic assays of Tephrosia vogelii against leishmania major infection in murine model: In vitro and in vivo. BMC Research Notes. 10(1). DOI: https://doi.org/10.1186/s13104-017-3022-x

[15] Komakech, R., Kang, Y., 2019. Ethnopharmacological potential of African cherry (Prunus africana). Journal of Herbal Medicine. 17-18, 100283. DOI: https://doi.org/10.1016/j.hermed.2019.100283

[16] Olela, B., Mbaria, J., Wachira, T., et al., 2020. Acute oral toxicity and anti-inflammatory and analgesic effects of aqueous and Methanolic stem bark extracts of Piliostigma thonningii (Schumach.). Evidence-Based Complementary and Alternative Medicine. 1-10. DOI: https://doi.org/10.1155/2020/5651390

[17] Magalhães, A., Carvalho, L.P., Costa, R., et al., 2021. Anti-leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis. International Journal of Infectious Diseases. 106, 83-90. DOI: https://doi.org/10.1016/j.ijid.2021.02.016

[18] De Lima, C.M., Magalhães, A.S., Costa, R., et al., 2021. High anti-leishmania IgG antibody levels are associated with severity of mucosal leishmaniasis. Frontiers in Cellular and Infection Microbiology. 11. DOI: https://doi.org/10.3389/fcimb.2021.652956

Downloads

Issue

Vol. 4 , Iss. 4 (October 2022)

Article Type

Articles

License

Copyright and Licensing

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

Journal of Zoological Research publishes accepted manuscripts under Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Authors who submit their papers for publication by Journal of Zoological Research agree to have the CC BY-NC 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for non-commercial use. As long as you follow the license terms and original source is properly cited, anyone may copy, redistribute the material in any medium or format, remix, transform, and build upon the material.

License Policy for Reuse of Third-Party Materials

If a manuscript submitted to the journal contains the materials which are held in copyright by a third-party, authors are responsible for obtaining permissions from the copyright holder to reuse or republish any previously published figures, illustrations, charts, tables, photographs, and text excerpts, etc. When submitting a manuscript, official written proof of permission must be provided and clearly stated in the cover letter.
The editorial office of the journal has the right to reject/retract articles that reuse third-party materials without permission.

Journal Policies on Data Sharing

We encourage authors to share articles published in our journal to other data platforms, but only if it is noted that it has been published in this journal.